Partners

UshTher objective of developing a clinical trial to test both the safety and efficacy of subretinal administrations of dual AAV8 vectors in the retina of USHIB patients will be achieved through a unique, very competitive consortium which brings together academic and industrial Partners with internationally-recognized expertise in gene therapy and ophthalmology.

UShTher partners at a glance

• Telethon Institute of Genetics and Medicine -TIGEM, Naples, Italy

• Genethon, Paris, France

• Genosafe, Evry, France

• Eye Clinic, University of Campania Luigi Vanvitelli, Naples, Italy

• IIS-FJD, Department of Medical Genetics UH-Fundacion Jimenez Diaz, Madrid, Spain

• Rotterdam Ophthalmic Institute, Rotterdam Eye Hospital, Rotterdam, The Netherlands

• Reithera, Rome, Italy

• Center of Biostatistics for Clinical Epidemiology, Università Milano-Bicocca, Milan, Italy